F
Foundation Medicine
Genomic Profiling for Cancer
Cambridge, MA
2,000+
About Foundation Medicine
Industry:
Diagnostics
Founded:
2010
Founders:
Michael Pellini, Vincent Miller, Doron Lipson
Status:
Subsidiary of Roche
Funding & Growth
Total Raised:
$500M+ pre-acquisition
Valuation:
Part of Roche
Stage:
Acquired
Key Investors:
Roche (parent company)
✓ Pros
- • Leader in comprehensive genomic profiling
- • Strong clinical oncology impact
- • Cambridge, MA location
- • Roche backing and stability
- • FDA-approved tests
✗ Cons
- • Roche integration challenges
- • Some startup culture lost
- • Competitive CDx market
- • Large company processes emerging